RENE — ReNeuron Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for ReNeuron, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
C2019 March 31st | 2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.2 | -13.9 | -13.4 | -11.1 | -6.66 |
| Depreciation | |||||
| Non-Cash Items | -0.024 | 0.652 | 1.26 | 0.482 | 0.118 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.93 | -1.51 | 5.72 | 2.84 | -1.21 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -11.9 | -14.3 | -6.05 | -7.41 | -7.48 |
| Capital Expenditures | -0.239 | -0.119 | -0.025 | -0.302 | -0.22 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.342 | 0.3 | 0.027 | 2.53 | 4.13 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.103 | 0.181 | 0.002 | 2.22 | 3.91 |
| Financing Cash Flow Items | 4.36 | 6.26 | -8.74 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.37 | 6.32 | 8.61 | -0.134 | -0.147 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.48 | -7.81 | 2.08 | -5.16 | -3.4 |